In NIH-heavy orgs, “build” isn’t a decision. It’s a reflex. Engineers don’t evaluate buy/partner/build. They default to build—either because they assume nothing good exists, or because they quietly discount the true internal costs until the spreadsheet says what they want it to say. Sometimes that reflex produces real advantage. Most of the time, it produces …
Continue reading “The NIH Tax: How “Not Invented Here” Quietly Kills Your Margin and Your Roadmap”